Wiser & Stronger – Life after Metastatic Melanoma

By Cody R. Barnett, MRA Director of Communications | 20 July 2018 In Melanoma Stories, Treatment

For Derrick, it all started with headaches. For the first time in his life, this otherwise perfectly healthy father of two, knew something was wrong.

Read More


Uveal ‘Clusters’ in Auburn, AL and Huntersville, NC

By Cody R. Barnett, MRA Director of Communications | 18 July 2018 In Allies & Partnerships, Melanoma Stories, News, Science, Treatment

When we talk about melanoma, it’s easy to forget that cutaneous – the most common variety that forms on the skin – isn’t the only game in town. Uveal represents about 5% of all melanomas diagnosed each year. So, when dozens of people from two towns in North Carolina and Alabama were diagnosed with the rare cancer alarm bells sounded.

Read More


Self-Care is Non-Negotiable: “How Early Detection Saved My Life”

By Charles Brodine, MRA Intern | 15 July 2018 In Melanoma Stories, Prevention

Jackie Labrecque’s life changed with a single phone call when her dermatologist called to tell her that the mole that she tried to ignore for months was melanoma.

Read More


Applying AI to Melanoma Detection

5 July 2018 In Prevention, Science

Is AI the future of detecting melanoma early, when it is easiest to cure?

Read More


Join the Ready. Raise. Rise. Pic Your Power Challenge!

20 June 2018 In Allies & Partnerships

We're thrilled to let you know that we are participating in Ready. Raise. Rise., a campaign sponsored by Bristol-Myers Squibb to raise awareness of immunotherapy (sometimes called immuno-oncology) research, including the emerging area of biomarkers. This year, Ready. Raise. Rise. is introducing the Pic Your Power challenge and we hope that you'll take part!

Read More


Making the Most Out of Immunotherapy

11 June 2018 In Science, Treatment

Learn what MRA-funded investigators are doing to optimize immunotherapy for patients.

Read More


We’ve Teamed Up with the American Cancer Society

By Cody R. Barnett, MRA Director of Communications | 7 June 2018 In Allies & Partnerships, Science, Treatment

American Cancer Society and Melanoma Research Alliance have united to fund lifesaving research aimed at reducing side effects and improving outcomes for patients treated with immunotherapy.

Read More


In Loving Memory of Rusty Cline

4 June 2018 In Melanoma Stories

Late last month we received word that Rusty Cline, an inspiring advocate and part of the MRA family, succumbed to melanoma after his diagnosis in 2006.

Read More



American Cancer Society and Melanoma Research Alliance Fund Five Innovative Approaches to Reduce Immunotherapy Side Effects

10 May 2018 In Allies & Partnerships, Science

As the world marks Melanoma Awareness Month, the American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) selected the first group of scientists to receive newly established research grants to investigate how to reduce rare, but serious, side effects resulting from cancer treatments with checkpoint inhibitors, a type of immunotherapy.

Read More


Login

×